Christine A. Nash

CIK: 0001554403

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (50.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RLYB

Rallybio Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

RLYB
Rallybio Corp
Oct 28, 2026
Exercise(M)
Direct
3.6K shares at avg. $2.38$8K
RLYB
Rallybio Corp
May 13, 2025
Award(A)
Option (Right to Buy)
Direct
28.5K shares-

		Type	Shares	Price		Ownership
Oct 28, 2026	RLYB Rallybio Corp	Exercise(M)	3,562	$2.38	$8,478	Direct
May 13, 2025	RLYB Rallybio Corp	Award(A) Option (Right to Buy)	28,500	-	-	Direct

1-2 of 2 transactions

About Nash Christine A

Nash Christine A (SEC CIK 0001554403) files insider reports with the SEC as Director of Rallybio Corp (RLYB).

Signal8 holds 2 ownership filings by Nash Christine A, all Form 4s, filed between May 15, 2025 and Oct 30, 2026. Those filings report 2 transactions, from May 13, 2025 to Oct 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Nash Christine A's filings is in EAST BERLIN, CT.

Recent filings by Nash Christine A

Oct 28, 2026: Option exercise of RLYB shares (Form 4, code M).
May 13, 2025: Grant or award of RLYB derivative securities (Form 4, code A).

Other insiders filing for Rallybio Corp (RLYB)

Lieber Jonathan I, Chief Financial Officer
HUNT RONALD, Director
Uden Stephen, Chief Executive Officer
Chung Wendy, Director
Soteropoulos Paula, Director
Boudreau Helen M, Director

How to read Form 4 transaction codes